Salivary gland sparing in the treatment of head and neck cancer

References

• Vissink A, Jansma J, Spijkervet F, Burlage F, Coppes R. The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia. Gerodontology6, 95–101 (1987).
   PubMed Web of Science ®Google Scholar
• Hamlet S, Faull J, Klein B et al. Mastication and swallowing in patients with post-irradiation xerostomia. Int. J. Radiat. Oncolol. Biol. Phys.37, 789–796 (1997).
   PubMed Web of Science ®Google Scholar
• Logemann J, Pauloski B, Rademaker A et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck25, 432–437 (2003).
   PubMed Web of Science ®Google Scholar
• Talmi Y, Horowitz Z, Bedrin L et al. Quality of life of nasopharyngeal cancer patients. Cancer94, 1012–1017 (2002).
   PubMed Web of Science ®Google Scholar
• Nguyen N, Sallah S, Karlsson U, Antoine J. Combined chemotherapy and radiotherapy for head and neck malignancies. Cancer94, 1131–1141 (2002).
   PubMed Web of Science ®Google Scholar
• Hammerlid E, Taft C. Health-related quality of life in long term head and neck cancer survivors: a comparison with general population norms. Br. J. Cancer84, 149–156 (2001).
   PubMed Web of Science ®Google Scholar
• Hammerlid E, Bjordal K, Ahlner-Elmqvvist M et al. A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope111, 669–680 (2001).
   PubMed Web of Science ®Google Scholar
• Bjordal K, Ahlner-Elmqvvist M, Hammerlid E et al. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope111, 1440–1452 (2001).
   PubMed Web of Science ®Google Scholar
• Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer – a longitudinal study. Head Neck23, 113–125 (2001).
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J. Clin. Oncol.26(22), 3770–3776 (2008).
   PubMed Web of Science ®Google Scholar
• Ringash J, Bezjak A. A structured review of quality-of-life instruments for head and neck cancer patients. Head Neck23(3), 201–213 (2001).
   PubMed Web of Science ®Google Scholar
• Hassan S, Weymuller E. Assessment of quality of life in head and neck cancer patients. Head Neck15(6), 485–496 (1993).
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Kim H, Terrell J, Marsh L, Dawson L, Ship J. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys.50(3), 695–704 (2001).
   PubMed Web of Science ®Google Scholar
• Ringash J, Warde P, Lockwood G, O’Sullivan B, Waldron J, Cummings B. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int. J. Radiat. Oncol. Biol. Phys.61, 1403–1407 (2005).
   PubMed Web of Science ®Google Scholar
• Scrimger R, Kanji A, Parliament M et al. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy. Am. J. Clin. Oncol.30(3), 271–277 (2007).
   PubMed Web of Science ®Google Scholar
• Beetz I, Burlage FR, Bijl HP et al. The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire. Radiother. Oncol.97(1), 127–131 (2010)
   PubMed Web of Science ®Google Scholar
• Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys..66(2), 445–453 (2006).
   PubMed Web of Science ®Google Scholar
• Bergonie J. Sur quelques formes de reactions precoses après des irradiations [French]. Arch. Elect. Med.19, 241–245 (1911).
   Google Scholar
• Franzen L, Funegard U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Eur. J. Cancer28, 457–462 (1992).
   PubMed Web of Science ®Google Scholar
• Cooper J, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int. J. Radiat. Oncol. Biol. Phys.30, 1141–1164 (1995).
   Web of Science ®Google Scholar
• Liem I, Olmos R, Balm A, Keus R, Van Tinteren H, Takes R. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur. J. Nucl. Med.23, 1485–1490 (1996).
   PubMedGoogle Scholar
• Funegard U, Johansson I, Franzen L, Ericson T, Nystrom H, Henriksson R. Rat salivary gland function after fractionated irradiation. Acta Oncologica36, 191–198 (1997).
   PubMed Web of Science ®Google Scholar
• Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer5, 281–288 (1997).
   PubMed Web of Science ®Google Scholar
• Vissink A, Mitchell JB, Baum BJ et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int. J. Radiat. Oncol. Biol. Phys.78(4), 983–991 (2010).
   PubMed Web of Science ®Google Scholar
• Jensen SB, Pedersen AM, Vissink A et al. Salivary gland hypofunction/xerostomia section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer18(8), 1039–1060 (2010).
   PubMed Web of Science ®Google Scholar
• Liu RP, Fleming TJ, Toth BB, Keene HJ. Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg. Oral. Med. Oral Pathol.70(6), 724–729 (1990).
   PubMedGoogle Scholar
• Roesink J, Moerland M, Hoekstra A et al. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume relationships. Int. J. Radiat. Oncol. Biol. Phys.58, 1451–1460 (2004).
   PubMed Web of Science ®Google Scholar
• Konings A, Coppes R, Vissink A. On the mechanism of salivary gland radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys.62, 1187–1194 (2005).
   PubMed Web of Science ®Google Scholar
• Ferguson D. Salivary glands and saliva. In: Applied Physiology of the Mouth. Lavelle CLB (Ed.). Wright, Bristol, UK (1975).
   Google Scholar
• Cherry C, Glucksmann A. Injury and repair following irradiation of salivary glands of rats. Br. J. Radiol.32, 596–608 (1959).
   PubMed Web of Science ®Google Scholar
• Glucksmann A, Cherry C. The induction of adenomas by the irradiation of salivary glands of rats. Radiat. Res.17, 186–202 (1962).
   PubMed Web of Science ®Google Scholar
• Dreizen S, Brown L, Handler S, Levy B. Radiation-induced xerostomia in cancer patients. Effect on salivary and serum electrolytes. Cancer38, 273–278 (1976).
   PubMed Web of Science ®Google Scholar
• Stern M, Turner J, Lett L, Mincer H, Mcginnis JP. Electron microscopic changes in rat parotid and submandibular glands subsequent to total body irradiation with fast neutrons. Oral Surg. Oral Med. Oral Pathol.42, 620–630 (1976).
   PubMedGoogle Scholar
• Vissink A, Gravenmade E, Ligeon E, Konings A. A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Rad. Res.124, 259–265 (1990).
   PubMed Web of Science ®Google Scholar
• Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother. Oncol.61, 271–274 (2001).
   PubMed Web of Science ®Google Scholar
• Funegard U, Franzen L, Ericson T, Henriksson R. Parotid saliva composition during and after irradiation of head and neck cancer. Eur. J. Cancer4, 230–330 (1994).
   Google Scholar
• Murdoch-Kinch CA, Kim HM, Vineberg KA, Ship JA, Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys72(2), 373–382 (2008).
   PubMed Web of Science ®Google Scholar
• Liu XK, Su Y, Jha N et al. Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes. Head Neck33(3), 389–395. (2011).
   PubMed Web of Science ®Google Scholar
• Valdez IH, Atkinson JC, Ship JA, Fox PC. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int. J. Radiat. Oncol. Biol. Phys.25(1), 41–47 (1993).
   PubMed Web of Science ®Google Scholar
• Coppes RP, Vissink A, Konings AW. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules. Radiother. Oncol.63(3), 321–328 (2002).
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Ten Haken R, Kim H, Marsh L, Ship J. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys.45, 577–587 (1999).
   PubMed Web of Science ®Google Scholar
• Heft MW, Baum BJ. Unstimulated and stimulated parotid salivary flow rate in individuals of different ages. J. Dent. Res.63, 1182–1185 (1984).
   PubMed Web of Science ®Google Scholar
• Ship JA, Fox PC, Baum BJ. How much saliva is enough? Normal function defined. J. Am. Dent. Assoc.122, 63–69 (1991).
   PubMed Web of Science ®Google Scholar
• Ghezzi EM, Lange LA, Ship JA. Determination of variation of stimulated salivary flow rates. J. Dent. Res.79(11), 1874–1878 (2000).
   PubMed Web of Science ®Google Scholar
• Burlage FR, Pijpe J, Coppes RP et al. Variability of flow rate when collecting stimulated human parotid saliva. Eur. J. Oral Sci.113(5), 386–390 (2005).
   PubMed Web of Science ®Google Scholar
• Münter M, Hoffner S, Herfarth K et al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int. J. Radiat. Oncol. Biol. Phys.67(3), 651–659 (2007).
   PubMed Web of Science ®Google Scholar
• Munter M, Karger C, Hoffner S et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int. J. Radiat. Oncol. Biol. Phys.58, 175–184 (2004).
   PubMed Web of Science ®Google Scholar
• Kohn W, Ship J, Atkinson J, Patton L, Fox P. Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J. Oral Pathol. Med.21(2), 70–74 (2006).
   Google Scholar
• Bussels B, Maes A, Flamen P et al. Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother. Oncol.73, 297–306 (2004).
   PubMed Web of Science ®Google Scholar
• Buus S, Grau C, Munk OL, Bender D, Jensen K, Keiding S. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer. Radiother. Oncol.73, 289–296 (2004).
   PubMed Web of Science ®Google Scholar
• Kan T, Kodani K, Michimoto K, Fuji S, Ogawa T. Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys.77, 1030–1038 (2010).
   PubMed Web of Science ®Google Scholar
• Lee F, King A, Kam M, Ma B, Yeung D. Radiation injury of the parotid glands during treatment for head and neck cancer: Assessment using dynamic contrast-enhanced MR Imaging. Radiat. Res.175, 291–296 (2011).
   PubMed Web of Science ®Google Scholar
• Hazuka MB, Martel MK, Marsh L, Lichter AS, Wolf GT. Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning. Int. J. Radiat. Oncol. Biol. Phys.27, 731–737 (1993).
   PubMed Web of Science ®Google Scholar
• Jones R, Takeuchi T, Eisbruch A, D’Hondt E, Hazuka M, Ship J. Ipsilateral parotid sparing in head and neck cancer patients who receive radiation therapy: results after 1 year. Oral Surg. Oral Med.81, 642–648 (1996).
   Google Scholar
• Leibel SA, Kutcher GJ, Harrison LB et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys.20, 823–833 (1991).
   PubMed Web of Science ®Google Scholar
• Maes A, Weltens C, Flamen P et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother. Oncol.63, 203–211 (2002).
   PubMed Web of Science ®Google Scholar
• Chen A, Marsano J, Perks J et al. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy ‘better’ than step-and-shoot IMRT? Technol. Cancer Res. Treat.10, 171–177 (2011).
   PubMed Web of Science ®Google Scholar
• Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study. Int. J. Radiat. Oncol. Biol. Phys.46, 195–205 (2000).
   PubMed Web of Science ®Google Scholar
• Saarilahti K, Kouri M, Collan J et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother. Oncol.74, 251–258 (2005).
   PubMed Web of Science ®Google Scholar
• Münter M, Karger C, Hoffner S et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int. J. Radiat. Oncol. Biol. Phys.58, 175–184 (2004).
   PubMed Web of Science ®Google Scholar
• Parliament M, Scrimger R, Anderson S et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys.58, 663–673 (2004).
   PubMed Web of Science ®Google Scholar
• Vergeer M, Doornaert P, Rietveld D et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a non-randomized prospective study using a standardized follow-up program. Int. J. Radiat. Oncol. Biol. Phys.74, 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Chao K, Deasy J, Markman J et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation theray: initial results. Int. J. Radiat. Oncol. Biol. Phys.49, 907–916 (2001).
   PubMed Web of Science ®Google Scholar
• Hsiung C, Ting H, Huang H, Lee C, Huang E, Hsu H. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: Preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.66, 454–461 (2006).
   PubMed Web of Science ®Google Scholar
• Kam M, Teo P, Chau R et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int. J. Radiat. Oncol. Biol. Phys.60, 1440–1450 (2004).
   PubMed Web of Science ®Google Scholar
• Nutting C, Morden J, Harrington K et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a Phase 3 multicentre randomized control trial. Lancet Oncol.12, 127–136 (2011).
   PubMed Web of Science ®Google Scholar
• Pow E, Kwong D, McMillan A et al. Xerostomia and quality of life after intensity modulated vs conventional radiotherapy for early stage nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.66, 981–991 (2006).
   PubMed Web of Science ®Google Scholar
• Kam MK, Leung SF, Zee B et al. Prospective randomized study of intensity modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J. Clin. Oncol.25, 4873–4879 (2007).
   PubMed Web of Science ®Google Scholar
• Roesink J, Moerland M, Battermann J et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int. J. Radiat. Oncol. Biol. Phys.51, 938–946 (2001).
   PubMed Web of Science ®Google Scholar
• Houweling A, Philppens M, Dijkema T, Roesink J. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int. J. Radiat. Oncol. Biol. Phys.76, 1259–1265 (2010).
   PubMed Web of Science ®Google Scholar
• Dijkema T, Raaijmakers C, Ten Haken R et al. Parotid gland function after radiotherapy: the combined Michigan and Utrecht experience. Int. J. Radiat. Oncol. Biol. Phys.78, 449–453 (2010).
   PubMed Web of Science ®Google Scholar
• Blanco A, Chao K, Naqa I et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.62, 1055–1069 (2005).
   PubMed Web of Science ®Google Scholar
• Scrimger R, Stavrev P, Parliament M et al. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect. Int. J. Radiat. Oncol. Biol. Phys.60, 178–185 (2004).
   PubMed Web of Science ®Google Scholar
• Dawes C. Factors influencing salivary flow rate and composition. In: Saliva and Oral Health (Second Edition). Edgar WM, O’Mullane DM (Eds). British Dental Journal, London, UK, 27–41 (1996).
   Google Scholar
• Schneyer LH. Source of resting total mixed saliva of man. J. Appl. Physiol.9, 79–81 (1956).
   PubMed Web of Science ®Google Scholar
• Jha N, Seikaly H, McGaw T, Coulter L. Submandibular gland transfer prevents radiation-induced xerostomia. Int. J. Radiat. Oncol. Biol. Phys.46, 7–11 (2000).
   PubMed Web of Science ®Google Scholar
• Jha N, Seikaly H, Harris J et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother. Oncol.66, 283–289 (2003).
   PubMed Web of Science ®Google Scholar
• Seikaly H, Jha N, Harris J et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch. Otolaryngol. Head Neck Surg.130, 956–961 (2004).
   PubMedGoogle Scholar
• Pathak KA, Bhalavat RL, Mistry RC et al. Upfront submandibular gland transfer in pharyngeal cancers. Oral Oncol.40, 960–963 (2004).
   PubMed Web of Science ®Google Scholar
• Liu XK, Su Y, Jha N et al. Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes. Head Neck.33(3), 389–395 (2011).
   PubMed Web of Science ®Google Scholar
• Saarilahti K, Kouri M, Collan J et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother. Oncol.78, 270–275 (2006).
   PubMed Web of Science ®Google Scholar
• Wang Z, Yan C, Zhang Z et al. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study. Int. J. Radiat. Oncol. Biol. Phys. DOI: 10.1016/j.ijrobp.2010.07.1990 (2010) (Epub ahead of print).
   Google Scholar
• Saibishkumar EP, Jha N, Scrimger R et al. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study. Radiother. Oncol.85, 98–104 (2007).
   PubMed Web of Science ®Google Scholar
• Jellema A, Slotman B, Muller M et al. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: a prospective randomized study in squamous cell head and neck cancer. Cancer107, 544–553 (2006).
   PubMed Web of Science ®Google Scholar
• Veerasarn V, Phromratanapongse P, Suntornpong N et al. Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function. J. Med. Assoc. Thai89, 2056–2067 (2006).
   PubMedGoogle Scholar
• Wasserman TH, Brizel DM, Henke M et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, Phase III trial. Int. J. Radiat. Oncol. Biol. Phys.63, 985–990 (2005).
   PubMed Web of Science ®Google Scholar
• Antonadou D, Pepelassi M, Synodinou M et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys.52, 739–747 (2002).
   PubMed Web of Science ®Google Scholar
• Buentzel J, Micke O, Adamietz A et al. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: az randomized placebo-controlled Phase III study. Int. J. Radiat. Oncol. Biol. Phys.64, 684–691 (2006).
   PubMed Web of Science ®Google Scholar
• Vacha P, Fehlauer F, Mahlmann B et al. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Strahlenther. Onkol.179, 385–389 (2003).
   PubMed Web of Science ®Google Scholar
• Hensley M, Hagerty K, Kewalramani T et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J. Clin. Oncol.27, 127–145 (2009).
   PubMed Web of Science ®Google Scholar
• Ozsahin M, Betz M, Matzinger O et al. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy. Arch. Otolaryngol. Head Neck Surg.132, 141–145 (2006).
   PubMed Web of Science ®Google Scholar
• Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined modality treatment for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys.69, 1361–1368 (2007).
   PubMed Web of Science ®Google Scholar
• Fox P, Atkinson J, Macynski A et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch. Intern. Med.151, 1149–1152 (1991).
   PubMed Web of Science ®Google Scholar
• Burlage F, Faber H, Kampinga H, Langendijk J, Vissink A, Coppes R. Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands. Radiother. Oncol.90(2), 253–256 (2009).
   PubMed Web of Science ®Google Scholar
• Valdez I, Wolff A, Atkinson J, Macynski A, Fox P. Use of pilocarpine during head an neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer71(5), 1848–1851 (1993).
   PubMed Web of Science ®Google Scholar
• Scarantino C, LeVegue F, Swan R et al. Effect of pilocarpine during radiation therapy: results of RTOG 97–09, a Phase III randomized study in head and neck cancer patients. J. Support Oncol.4, 252–258 (2006).
   PubMedGoogle Scholar
• Gornitsky M, Shenouda G, Sultanem K et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg. Oral Med.98, 45–52 (2004).
   Google Scholar
• Mateos J, Setoain X, Ferre J et al. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiatied tumours. Nucl. Med. Commun.22, 651–656 (2001).
   PubMed Web of Science ®Google Scholar
• Burlage FR, Roesink JM, Kampinga HH et al. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int. J. Radiat. Oncol. Biol. Phys.70(1), 14–22 (2008).
   PubMed Web of Science ®Google Scholar
• Jha N, Seikaly H, Harris J et al. Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck31, 234–243 (2009).
   PubMed Web of Science ®Google Scholar
• Rieger JM, Jha N, Lam Tang JA, Harris J, Seikaly H. Functional outcomes related to the prevention of radiation-induced xerostomia: Oral pilocarpine versus submandibular salivary gland transfer. Head Neck. DOI: 10.1002/hed.21682 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Greenspan D, Daniels TE. Effectiveness of pilocarpine in postradiation xerostomia. Cancer59(6), 1123–1125 (1987).
   PubMed Web of Science ®Google Scholar
• LeVeque F, Montgomery M, Potter D et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J. Clin. Oncol.11, 1124–1131 (1993).
   PubMed Web of Science ®Google Scholar
• Johnson J, Ferretti G, Nethery W et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N. Engl. J. Med.329, 390–395 (1993).
   PubMed Web of Science ®Google Scholar
• Konings AW, Cotteleer F, Faber H, van Luijk P, Meertens H, Coppes RP. Volume effects and region-dependent radiosensitivity of the parotid gland. Int. J. Radiat. Oncol. Biol. Phys.62(4), 1090–1095 (2005).
   PubMed Web of Science ®Google Scholar
• Konings AW, Faber H, Cotteleer F, Vissink A, Coppes RP. Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. Int. J. Radiat. Oncol. Biol. Phys.64(1), 98–105 (2006).
   PubMed Web of Science ®Google Scholar
• Konings AW, Faber H, Vissink A, Coppes RP. Radioprotective effect of amifostine on parotid gland functioning is region dependent. Int. J. Radiat. Oncol. Biol. Phys.63(5), 1584–1591 (2005).
   PubMed Web of Science ®Google Scholar
• Baum BJ, Zheng C, Alevizos I et al. Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol.46(1), 4–8 (2009).
   PubMed Web of Science ®Google Scholar
• Coppes RP, Stokman MA. Stem cells and the repair of radiation-induced salivary gland damage. Oral Dis.17(2), 143–153 (2011).
   PubMed Web of Science ®Google Scholar